Social Security Mexican Institute Report issue

Government Phase 3 Phase 4

Organization Overview

First Clinical Trial
2010
NCT01842191
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

MEXICAN SOCIAL SECURITY INSTITUTE

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Multiple Sclerosis (Phase 4)

Multiple Sclerosis, Relapsing-Remitting (Phase 4)

Sclerosis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 5